Shubha Bhat

22PUBLICATIONS
14CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cross-sectional analysisClinical pharmacy and pharmacy practiceGene and molecular therapyCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jan 13, 2025
Guselkumab: A New Therapeutic Option for the Treatment of Moderately to Severely Active Ulcerative Colitis.

Shubha Bhat, David Choi

|Feb 12, 2024
Mirikizumab: A New Therapeutic Option for the Treatment of Ulcerative Colitis.

David Choi, Hilary Sheridan, Shubha Bhat

|Jan 23, 2024
Etrasimod: A Sphingosine-1-Phosphate Receptor Modulator for the Treatment of Ulcerative Colitis.

David Choi, Michelle Becker, Marina Ivanov

|Jan 19, 2024
Biosimilars in IBD: What Every Clinician Needs to Know.

Anthony Angyal, Shubha Bhat

|Aug 31, 2023
Defining the Roles of Inflammatory Bowel Disease Clinical Pharmacists in the United States: A Systematic Review and National RAND/UCLA Consensus.

Shubha Bhat, Ruishen Lyu, Mitali Agarwal

|Jul 14, 2023
Safety and Monitoring of Inflammatory Bowel Disease Advanced Therapies.

Shubha Bhat, Benjamin Click, Miguel Regueiro

Pageof 4

Frequent Collaborators

4 joint publications

David Choi

2 joint publications

Katy E Trinkley

1 joint publications

Alison Lh Quinn

1 joint publications

James C Lee